A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point-of-care diagnostics in low-resource settings
Haemophilia
.
2023 Sep;29(5):1376-1381.
doi: 10.1111/hae.14853.
Epub 2023 Sep 1.
Authors
Juliana Hagembe
1
,
Pierre Toulon
2
,
Assad Haffar
1
,
Alain Baumann
1
,
Annette Bowyer
3
,
Silmara Montalvao
4
,
Emna Gouider
5
,
Carlos de Brasi
6
,
Chen Dong
7
,
Glenn F Pierce
1
Affiliations
1
World Federation of Hemophilia, Montreal, QC, Canada.
2
Service d'hématologie biologique, Hôpital Pasteur, CHU, Nice, France.
3
Department of Coagulation, Royal Hallamshire, Hospital, Sheffield, UK.
4
Laboratory Hemostasis and Thrombosis, Hematology Center of University of Campinas, Campinas, Brazil.
5
Aziza Othmana Hospital, Haemophilia Centre, Tunis Medical School, Tunis, Tunisia.
6
Academia Nacional de Medicina, Buenos Aires, Argentina.
7
Hematopathology, Mayo Clinic, Minnesota, USA.
PMID:
37655507
DOI:
10.1111/hae.14853
No abstract available
Publication types
Letter
MeSH terms
Hemophilia A* / diagnosis
Humans
von Willebrand Diseases* / diagnosis